(Q34035026)

30 July 2017

1 reference

title

Growth hormone secretagogues as corticotrophin-releasing factors (English)

1 reference

30 July 2017

Ghigo E

1

1 reference

30 July 2017

Arvat E

series ordinal

2

1 reference

30 July 2017

Camanni F

series ordinal

3

1 reference

30 July 2017

publication date

1 April 1998

1 reference

Growth Hormone & I G F Research

30 July 2017

published in

1 reference

30 July 2017

volume

8 Suppl B

1 reference

30 July 2017

page(s)

145-148

1 reference

Small peptides as potent releasers of growth hormone

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980040-3

7 January 2021

Growth hormone-releasing peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980040-3

7 January 2021

Binding of a growth hormone releasing hexapeptide to specific hypothalamic and pituitary binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980040-3

7 January 2021

A receptor in pituitary and hypothalamus that functions in growth hormone release

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980040-3

7 January 2021

Effects of acute and repeated intravenous administration of L-692,585, a novel non-peptidyl growth hormone secretagogue, on plasma growth hormone, IGF-1, ACTH, cortisol, prolactin, insulin, and thyroxine levels in beagles

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980040-3

7 January 2021

Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980040-3

7 January 2021

Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980040-3

7 January 2021

Effects of GHRP-2 and Hexarelin, Two Synthetic GH-Releasing Peptides, on GH, Prolactin, ACTH and Cortisol Levels in Man. Comparison with the Effects of GHRH, TRH and hCRH

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980040-3

7 January 2021

The effect of an opiate antagonist on the hormonal changes induced by hexarelin

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980040-3

7 January 2021

Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980040-3

7 January 2021

Adrenocorticotropin- and Cortisol-Releasing Effect of Hexarelin, a Synthetic Growth Hormone-Releasing Peptide, in Normal Subjects and Patients with Cushing's Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980040-3

7 January 2021

Hexarelin-induced growth hormone, cortisol, and prolactin release: a dose-response study.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980040-3

7 January 2021

Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980040-3

7 January 2021

Mediation by the central nervous system is critical to the in vivo activity of the GH secretagogue L-692,585.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980040-3

7 January 2021

A nonpeptidyl growth hormone secretagogue

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980040-3

7 January 2021

In vitro characterization of four novel classes of growth hormone-releasing peptide

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980040-3

7 January 2021

Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol release in normal man.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980040-3

7 January 2021

Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980040-3

7 January 2021

Growth hormone-releasing activity of growth hormone-releasing peptide-1 (a synthetic heptapeptide) in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980040-3

7 January 2021

The GH, prolactin, ACTH and cortisol responses to Hexarelin, a synthetic hexapeptide, undergo different age-related variations

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980040-3

7 January 2021

GH releasing peptides--structure and kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980040-3

7 January 2021

Arginine enhances the growth hormone-releasing activity of a synthetic hexapeptide (GHRP-6) in elderly but not in young subjects after oral administration

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980040-3

7 January 2021

Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980040-3

7 January 2021

Short-term administration of intranasal or oral Hexarelin, a synthetic hexapeptide, does not desensitize the growth hormone responsiveness in human aging

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980040-3

7 January 2021

Effects of histaminergic antagonists on the GH-releasing activity of GHRH or hexarelin, a synthetic hexapeptide, in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980040-3

7 January 2021

Effects of dexamethasone and alprazolam, a benzodiazepine, on the stimulatory effect of hexarelin, a synthetic GHRP, on ACTH, cortisol and GH secretion in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980040-3

7 January 2021

Induction of c-fos Messenger Ribonucleic Acid in Neuropeptide Y and Growth Hormone (GH)-Releasing Factor Neurons in the Rat Arcuate Nucleus Following Systemic Injection of the GH Secretagogue, GH-Releasing Peptide-6

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980040-3

7 January 2021

Widespread transcription of the growth hormone-releasing peptide receptor gene in neuroendocrine human tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980040-3

7 January 2021

10.1016/S1096-6374(98)80040-3

Identifiers

DOI

1 reference

30 July 2017

1 reference